The circulating IGF system and its relationship with 24-h glucose regulation and insulin sensitivity in healthy subjects

Clinical Endocrinology

Volumn 58, Issue 6, 2003, Pages 777-784

  Frystyk, Jan ^a   Nyholm, Birgit ^a   Skjærbæk, Christian ^a   Baxter, Robert C ^b   Schmitz, Ole ^a   Ørskov, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Aarhus Kommune Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; BLOOD PROTEINS; C-PEPTIDE; CIRCADIAN RHYTHM; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE; HOMEOSTASIS; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; STATISTICS, NONPARAMETRIC;

EID: 0038469956     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01791.x     Document Type: Article

References (36)

1. Baxter, R.C. (1990) Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. Journal of Clinical Endocrinology and Metabolism, 70, 1347-1353.
2. Baxter, R.C. (1994) Insulin-like growth factor binding proteins in the human circulation: a review. Hormone Research, 42, 140-144.
3. Baxter, R.C. (1995) Insulin-like growth factor binding proteins as glucoregulators. Metabolism, 44, 12-17.
4. Baxter, R.C. & Cowell, C.T. (1987) Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. Journal of Clinical Endocrinology and Metabolism, 65, 432-440.
5. Baxter, R.C. & Martin, J.L. (1986) Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. Journal of Clinical Investigations, 78, 1504-1512.
6. Bereket, A., Wilson, T.A., Blethen, S.L., Fan, J., Frost, R.A., Gelato, M.C. & Lang, C.H. (1996) Effect of short-term fasting on free/dissociable insulin-like growth factor-I concentrations in normal human serum. Journal of Clinical Endocrinology and Metabolism, 81, 4379-4384.
7. Cheetham, T.D., Jones, J., Taylor, A.M., Holly, J., Matthews, D.R. & Dunger, D.B. (1993) The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 36, 678-681.
8. Dai, Z., Xing, Y., Boney, C.M., Clemmons, D.R. & D'Ercole, A.J. (1994) Human insulin-like growth factor-binding protein-1 (hIGFBP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. Endocrinology, 135, 1316-1327.
9. De Meyts, P., Christoffersen, C.T., Urso, B., Wallach, B., Gronskov, K., Yakushiji, F. & Shymko, R.M. (1995) Role of the time factor in signaling specificity: application to mitogenic and metabolic signalling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism, 44, 2-11.
10. Firth, S.M., McDougall, F., McLachlan, A.J. & Baxter, R.C. (2002) Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analogue with reduced ternary complex-forming ability. Endocrinology, 143, 1669-1676.
11. Frystyk, J. (2000) Role of IGFBP-1 in glucose regulation? Acta Pœediatrica, 89, 1025-1031.
12. Frystyk, J., Skjærbæk, C., Dinesen, B. & Ørskov, H. (1994) Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters, 348, 185-191.
13. Frystyk, J., Dinesen, B. & Ørskov, H. (1995a) Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regulations, 5, 169-176.
14. Frystyk, J., Vestbo, E., Skærbæk, C., Mogensen, C.E. & Ørskov, H. (1995b) Free insulin-like growth factors in human obesity. Metabolism, 44, 37-44.
15. Frystyk, J., Grøfte, T, Skjærbæk, C. & Ørskov, H. (1997) The effect of oral glucose on serum free insulin-like growth factor-I and -II in healthy adults. Journal of Clinical Endocrinology and Metabolism, 82, 3124-3127.
16. Frystyk, J., Højlund, K., Rasmussen, K.N., Jørgensen, S.P., Wildner-Christensen, M. & Ørskov, H. (2002) Development and clinical evaluation of a novel immunoassay for the binary complex of insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 in human serum. Journal of Clinical Endocrinology and Metabolism, 84, 2324-2328.
17. Guler, H.P., Zapf, J. & Froesch, E.R. (1987) Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. New England Journal of Medicine, 317, 137-140.
18. Heald, A.H., Cruickshank, J.K., Riste, L.K., Cade, J.E., Anderson, S., Greenhalgh, A., Sampayo, J., Taylor, W., Fraser, W., White, A. & Gibson, J.M. (2001) Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia, 44, 333-339.
19. Heuck, C., Skjærbæk, C., Ørskov, H. & Wolthers, O.D. (1999) Circadian variation in serum-free ultrafiltrable insulin-like growth factor I concentrations in healthy children. Pediatrics Research, 45, 733-736.
20. Ho, P.J. & Baxter, R.C. (1997) Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clinical Endocrinological, 46, 145-154.
21. Kahn, S.E., Bergman, R.N., Schwarts, M.W., Taborsky, G.J. Jr & Porte, D. Jr (1992) Short-term hyperglycerma and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. American Journal of Physiological Endocrinology and Metabolism, 262, E518-E523.
22. Le Roith, D., Bondy, C., Yakar, S., Liu, J.L. & Butler, A. (2001) The somatomedin hypothesis: 2001. Endocrine Reviews, 22, 53-74.
23. Lee, P.D., Giudice, L.C., Conover, C.A. & Powell, D.R. (1997) Insulin-like growth factor binding protein-1: recent findings and new directions. Proceedings of the Society of Experimental Biology Medicine, 216, 319-357.
24. Lewitt, M.S., Denyer, G.S., Cooney, G.J. & Baxter, R.C. (1991) Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology, 129, 2254-2256.
25. Mohamed-Ali, V., Pinkney, J.H., Panahloo, A., Cwyfan-Hughes, S., Holly, J.M. & Yudkin, J.S. (1999) Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clinical Endocrinological, 50, 221-228.
26. Mortensen, D.L., Won, W.B., Siu, J., Reifsnyder, D., Gironella, M., Etcheverry, T & Clark, R.G. (1997) Insulin-like growth factor binding protein-1 induces insulin release in the rat. Endocrinology, 138, 2073 -2080.
27. Moses, A.C., Young, S.C., Morrow, L.A., O'Brien, M. & Clemmons, D.R. (1996) Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes, 45, 91- 100.
28. Nyholm, B., Walker, M., Gravholt, C.H., Shearing, P.A., Sturis, J, Alberti, K.G., Holst, J.J. & Schmitz, O. (1999) Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of type II (noninsulin-dependent) diabetic parents: evidence of several aberrations. Diabetologia, 42, 1314-1323.
29. Nyomba, B.L., Berard, L. & Murphy, L.J. (1997) Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism, 82, 2177-2181.
30. Rajaram, S., Baylink, D.J. & Mohan, S. (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrine Reviews, 18, 801-831.
31. Rajkumar, K., Barron, D., Lewitt, M.S. & Murphy, L.J. (1995) Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology, 136, 4029-4034.
32. Sandhu, M.S, Heald, A.H., Gibson, J.M., Cruickshank, J.K., Dunger, D.B. & Wareham, N.J. (2002) Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet, 359, 1740-1745.
33. Travers, S.H., Labarta, J.I., Gargosky, S.E., Rosenfeld, R.G., Jeffers, B.W. & Eckel, R.H. (1998) Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children. Journal of Clinical Endocrinology and Metabolism, 83, 1935-1939.
34. Vaessen, N., Heutink, P., Janssen, J.A., Witteman, J.C., Testers, L., Hofman, A., Lamberts, S.W., Oostra, B.A., Pols, H.A. & van Duijn, C.M. (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes, 50, 637-642.
35. Yakar, S., Liu, J.L., Fernandez, A.M., Wu, Y., Schally, A.V., Frystyk, J., Chernausek, S.D., Mejia, W. & Le Roith, D. (2001) Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes, 50, 1110-1118.
36. Zapf, J., Froesch, E.R. & Schmid, C. (1999) Metabolic effects of IGFs. In: Contemporary Endocrinology: the IGF System. (eds R.G. Rosenfeld & C.T. Roberts Jr), pp. 577-616. Totowa, NJ: Humana Press Inc.